Clinical Trial Detail

NCT ID NCT03953235
Title A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Gritstone Oncology, Inc.
Indications

colorectal cancer

pancreatic ductal adenocarcinoma

Advanced Solid Tumor

lung non-small cell carcinoma

Therapies

GRT-C903 + GRT-R904 + Ipilimumab + Nivolumab

Age Groups: senior adult

Additional content available in CKB BOOST